SRD5A1 and infection: Taken together, R5020 or its derivatives, not metabolizable by 20α-HSD and SRD5A1, likely can maintain PR-mediated inhibition of pro-contractile and pro-inflammatory proteins in myometrium [14] and cervix, which may explain their great efficacy in the prevention of PTB induced by systemic or local infection in mice.